return equiti ttm
report fiscal fourth-quart revenu million year-over-year
street estim million million respect
weak quarter larg due slower-than-anticip impella growth
month march follow fda dear doctor letter impella rp manag believ
letter creat confus among surgeon regard safeti efficaci impella
indic name elect high-risk pci hrpci
follow public letter refocus much train
educ effort fiscal fourth quarter impella rp compani success
reacceler rp growth quarter compar last quarter came
expens hrpci estim deceler growth quarter domest
first third quarter cardiogen shock
growth also came expect compar last quarter less
impact compani focu rp given higher util rp shock
guidanc given slower-than-expect end fiscal manag provid fiscal
guidanc street manag initi expect specif full-
year sale guidanc came million million well
street estim million million head print
manag note fiscal fourth-quart growth approxim lower guidanc
compani similarli decreas fiscal guid midpoint
impli manag anticip guid rang fiscal growth
line mid-to-high growth report past sever year
said manag note volum april alreadi start reacceler
march low though deliv consist
growth result manag start take action plan believ help
deliv sustain growth improv expect seen fiscal
specif alreadi creat two new region plan increas
sale educ headcount hire four addit medic offic
expand impella distribut channelal expect help improv
physician educ clinic outcom subsequ support impella util
manag expect new product launch like impella connect impella
expect back half year support momentum year add
new leg long-term sustain growth
make number cardiac-assist devic treat acut heart failur compani portfolio
highlight impella product first percutan catheter-bas cardiac assist devic
fda letter confus caus miss fourth quarter execut
win fundament remain strong
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
overal believ manag provid prudent conserv guidanc look assess speed
impella util return normal growth rate importantli believ issu identifi suggest
fundament chang market demand improv execut educ abl overcom recent
headwind compani also continu publish new clinic data support use impella believ
drive increas util april three compel dataset publish mean surviv rate iq
databas patient cardiogen shock vs surviv rate inova heart vascular institut
follow implement shock protocol vs month day data hrpci patient
percent patient left ventricular eject fraction greater equal vs
note manag strong track record set appropri guidanc subsequ execut key initi
quarter fell short expect believ fiscal set appropri perhap conserv
said expect stock becom somewhat show-m stori demonstr start
reacceler growth sustain believ room growth reacceler particularli back half
year salesforc initi take sever month come fruition new product launch slate later
conclus stock thought
bar set high given valuat believ manag appropri invest busi
support growth fiscal beyond believ compani focu execut educ initi
public clinic data new product launch start yield meaning benefit move fiscal
share current trade time calendar revenu estim million believ
premium warrant compani oper monopoli vastli under-penetrated market rate stock
domest sale million came million expect due previous discuss
neg impact fda dear doctor letter hrpci growth saw largest impact quarter
growth deceler last quarter said continu add new impella
center quarter addit locat led adopt impella cp rp manag
highlight continu momentum grow impella clinic back posit public shock
look fiscal expect year back-half load manag execut sale
educ initi first half set base acceler growth subsequ quarter launch
new product later year specif manag expect launch impella similar indic
longer use axillari access fourth quarter move full launch impella connect platform
year-end altogeth expect abl meet potenti deliv strong upsid fiscal
guidanc move year
impella connect fourth quarter impella connect launch hospit
manag anticip broad market roll-out expand center limit
launch yet meaning chang estim futur impella connect use see
sever advantag system expect account see better clinic econom outcom gain
confid use system increas util also believ system help becom
entrench hospit system make difficult custom switch longer term
solidifi posit market innov
sale million came million ahead expect driven continu momentum
germani growth japan million sale manag also note earli momentum
european market like switzerland franc itali though believ market still remain earli
develop stage estim assum minim contribut sale growth fiscal abiom
provid geograph guidanc manag note expect approxim million sale
japan fiscal million fiscal overal believ intern pick
momentum believ million fiscal estim conserv
profit deliv strong oper margin basi point estim despit
on-going invest train manufactur pipelin product well lower-than-expect product sale
quarter manag expect margin improv fiscal though remain dedic invest
initi believ support sustain long-term growth increas train market headcount
pipelin product clinic data expect fiscal oper margin rang
believ manag guidanc achiev compani continu leverag sales-and-market
invest lead higher impella sale estim oper margin fiscal
gross margin came basi point expect basi point year-over-year
compani benefit manufactur scale somewhat off-set continu roll-out impella connect optic
sensor cp inventori field swap though also prove transient
impella expect launch late fiscal domest continu think
potenti support long-term util impella similar design
eventu replac expect approv circulatori support allow physician
better wean sick patient extend hospit stay current minim impella sale
 given uncertainti time ramp commerci launch expect
market year-end look detail manag futur call
impella connect smartassist also expect enter full commerci launch fiscal
second half year recal impella connect wi-fi connect cardiac monitor servic
allow provid real-tim support hospit help improv hospit effici
intern hospit remot monitor smartassist advanc consol softwar allow physician
see new data consol like nativ cardiac output enabl effici wean process
ultim better recoveri nativ heart impella connect expect gener increment
revenu commerci strategi yet final smartassist come standard consol
stemi pivot trial approv fda anticip enrol begin octob
trial enrol total patient site across patient random
either standard care immedi reperfus delay reperfus support impella
primari endpoint trial infarct size percent left ventricular mass day
reperfus though intend run trial least year collect solid long-term evid
capabl chang standard care stemi patient
overal pivot trial larg line expect encourag manag
make larg invest expect million ensur result support long-term sustain
growth enrol begin octob file expect file enrol
complet still think approv least two year away believ import long-term growth
newpreviouschang newpreviouschang us impella growth margin margin summari chang modelfisc import disclosur
